Market research
AEMD Aethlon Medical Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 13.25
- Dividend yield
- Not available
- Beta
- 1.44
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US00808Y3071
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 13.25
- Dividend yield
- Not available
- Beta
- 1.44
About
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AEMD discussion.
5 years, 4 months ago
Aethlon Medical, Inc is currently in a long term uptrend where the price is trading 93.6% above its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 26.3.
Aethlon Medical, Inc's total revenue rose by 51.1% to $625K since the same quarter in the previous year.
Its net income has dropped by 198.1% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 73.5% to $-2M since the same quarter in the previous year.
Based on the above factors, Aethlon Medical, Inc gets an overall score of 3/5.